(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
Portfolio Pulse from Benzinga Insights
Takeda Pharmaceutical's (NYSE:TAK) short percent of float has risen 7.41% since its last report, with 8.99 million shares sold short, which is 0.29% of all regular shares available for trading. It would take traders 5.76 days to cover their short positions on average. The company's short interest is less than most of its peers, with an average of 3.71%.
July 14, 2023 | 8:31 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Takeda Pharmaceutical's short interest has increased, indicating a bearish sentiment among traders. However, its short interest is less than most of its peers.
An increase in short interest indicates that more traders are betting that the stock price will fall. This could put downward pressure on the stock price in the short term. However, the company's short interest is less than most of its peers, which could mitigate some of this pressure.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100